These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17895767)

  • 1. Contemporaneous H&E sections should be standard practice in diagnostic immunopathology.
    Hoda SA; Rosen PP
    Am J Surg Pathol; 2007 Oct; 31(10):1627. PubMed ID: 17895767
    [No Abstract]   [Full Text] [Related]  

  • 2. E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions.
    Goldstein NS; Bassi D; Watts JC; Layfield LJ; Yaziji H; Gown AM
    Am J Clin Pathol; 2001 Apr; 115(4):534-42. PubMed ID: 11293901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic immunohistochemistry of breast epithelial lesions].
    Balaton AJ; Guinebretière JM; Penault-Llorca F
    Ann Pathol; 2003 Dec; 23(6):570-81. PubMed ID: 15094595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions.
    MacGrogan G; Arnould L; de Mascarel I; Vincent-Salomon A; Penault-Llorca F; Lacroix-Triki M; Bibeau F; Baranzelli MC; Fridman V; Antoine M; Bécette V; Brouste V; Jacquemier J; Mathoulin-Pélissier S;
    Histopathology; 2008 May; 52(6):689-97. PubMed ID: 18397281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squamous cell carcinoma in situ of the breast: a light microscopic and immunohistochemical study of a previously undescribed lesion.
    Hayes MM; Peterse JL; Yavuz E; Vischer GH; Eusebi V
    Am J Surg Pathol; 2007 Sep; 31(9):1414-9. PubMed ID: 17721198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagenous spherulosis with lobular carcinoma in situ: a potential diagnostic pitfall.
    Hill P; Cawson J
    Pathology; 2007 Jun; 39(3):361-3. PubMed ID: 17558867
    [No Abstract]   [Full Text] [Related]  

  • 7. Distinctive biology of pleomorphic lobular carcinoma of the breast.
    Moe RE; Anderson BO
    J Surg Oncol; 2005 May; 90(2):47-50. PubMed ID: 15844193
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnostic pitfalls in mammary pathology. Case 1. In situ ductal carcinoma of low nuclear grade, with papillary, micropapillary and cribriform architecture].
    MacGrogan G
    Ann Pathol; 2009 Jun; 29(3):188-93. PubMed ID: 19619824
    [No Abstract]   [Full Text] [Related]  

  • 9. E-cadherin immunohistochemistry in breast pathology: uses and pitfalls.
    Canas-Marques R; Schnitt SJ
    Histopathology; 2016 Jan; 68(1):57-69. PubMed ID: 26768029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microinvasive carcinoma of the breast: can it be diagnosed reliably and is it clinically significant?
    Hoda SA; Prasad ML; Moore A; Hoda RS; Giri D
    Histopathology; 1999 Nov; 35(5):468-70. PubMed ID: 10583563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
    Rabban JT; Chen YY
    Hum Pathol; 2008 Feb; 39(2):175-83. PubMed ID: 18206495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillary lesions of the breast: selected diagnostic and management issues.
    Collins LC; Schnitt SJ
    Histopathology; 2008 Jan; 52(1):20-9. PubMed ID: 18171414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleomorphic carcinoma with osteoclastic giant cells of the breast: immunohistochemical differentiation between coexisting neoplastic and reactive giant cells.
    Kurokawa K; Mouri Y; Asano A; Kamei K; Iwata Y; Isogai M; Saga S; Ichihara S
    Pathol Int; 2009 Feb; 59(2):91-7. PubMed ID: 19154262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-institutional comparison of whole slide digital imaging and optical microscopy for interpretation of hematoxylin-eosin-stained breast tissue sections.
    Krishnamurthy S; Mathews K; McClure S; Murray M; Gilcrease M; Albarracin C; Spinosa J; Chang B; Ho J; Holt J; Cohen A; Giri D; Garg K; Bassett RL; Liang K
    Arch Pathol Lab Med; 2013 Dec; 137(12):1733-9. PubMed ID: 23947655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of immunohistochemistry for differential diagnosis between benign and malignant breast lesions.
    Moriya T; Kanomata N; Kozuka Y; Fukumoto M; Iwachido N; Hata S; Takahashi Y; Miura H; Ishida K; Watanabe M
    Breast Cancer; 2009; 16(3):173-8. PubMed ID: 19475479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fortuitous diagnosis in a uterine leiomyoma of metastatic lobular carcinoma of the breast.
    Liebmann RD; Jones KD; Hamid R; Lapsley M
    Histopathology; 1998 Jun; 32(6):577-8. PubMed ID: 9675605
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
    Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomopathological analysis of sentinel and nonsentinel lymph nodes in breast cancer: hematoxylin-eosin versus immunohistochemistry.
    Soares CT; Frederigue-Junior U; Luca LA
    Int J Surg Pathol; 2007 Oct; 15(4):358-68. PubMed ID: 17913942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luminal B breast tumors are not HER2 positive.
    Bhargava R; Dabbs DJ
    Breast Cancer Res; 2008; 10(5):404; author reply 405. PubMed ID: 18831725
    [No Abstract]   [Full Text] [Related]  

  • 20. Enophthalmos as initial manifestation of occult, mammogram-negative carcinoma of the breast.
    Shields CL; Stopyra GA; Marr BP; Moster ML; Shields JA
    Ophthalmic Surg Lasers Imaging; 2004; 35(1):56-7. PubMed ID: 14750765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.